Allogenic transplantation

PROCEDURE3 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, PETHEMA Foundation

Conditions

Acute Promyelocytic LeukemiaHaploidentical Allogeneic Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteRefractory Idiopathic Aplastic Anemia

Phase 2

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression

RecruitingNCT05126849

Assistance Publique - Hôpitaux de ParisHaploidentical Allogeneic Hematopoietic Stem Cell Transplantation, Refractory Idiopathic Aplastic Anemia

Start: 2022-01-06End: 2027-01-06Target: 31Updated: 2023-11-24

Phase 3

Randomised Prospective Comparison of the NMA Allograft and the Traditional Allograft in Acute Myeloid Leukaemia

Assistance Publique - Hôpitaux de ParisLeukemia, Myeloid, Acute

Start: 2005-07-31End: 2009-07-31Target: 100Updated: 2005-12-14

Phase 4

Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)

CompletedNCT00504764

PETHEMA FoundationAcute Promyelocytic Leukemia

Start: 2007-07-31End: 2014-10-31Target: 60Updated: 2014-10-28